Drug Interactions of Psychiatric and COVID-19 Medications
Open Access
- 30 May 2020
- journal article
- review article
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 11 (2) , 147-162
Abstract
Introduction: Coronavirus disease 2019 (COVID-19) has become a pandemic with 1771514 cases identified in the world and 70029 cases in Iran until April 12, 2020. The co-prescription of psychotropics with COVID-19 medication is not uncommon. Healthcare providers should be familiar with many Potential Drug-Drug Interactions (DDIs) between COVID-19 therapeutic agents and ...Keywords
This publication has 106 references indexed in Scilit:
- Can Antidepressants Prevent Pegylated Interferon-α/Ribavirin-Associated Depression in Patients with Chronic Hepatitis C: Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials?PLOS ONE, 2013
- The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamineEuropean Journal of Clinical Pharmacology, 2011
- Complex Drug Interactions of HIV Protease Inhibitors 1: Inactivation, Induction, and Inhibition of Cytochrome P450 3A by Ritonavir or NelfinavirDrug Metabolism and Disposition, 2011
- Pharmacokinetic Interactions between Etravirine and Non-Antiretroviral DrugsClinical Pharmacokinetics, 2011
- Rapid Clinical Induction of Hepatic Cytochrome P4502B6 Activity by RitonavirAntimicrobial Agents and Chemotherapy, 2008
- The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reportsEuropean Journal of Clinical Pharmacology, 2008
- Interaction Study of the Combined Use of Paroxetine and Fosamprenavir-Ritonavir in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2007
- Tricyclic antidepressant pharmacology and therapeutic drug interactions updatedBritish Journal of Pharmacology, 2007
- Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive casesBritish Journal of Clinical Pharmacology, 2007
- Overview of the Pharmacokinetics of FluvoxamineClinical Pharmacokinetics, 1995